| Literature DB >> 29177242 |
Elham Mohammadzadeh1,2, Fatemeh-Sadat Amjadi3,4, Mansoureh Movahedin5, Zahra Zandieh3,4, Zohreh Nazmara4, Neda Eslahi5, Peymaneh Shirinbayan6, Hamid Reza Asgari3, Nahid Azad2, Maryam Salimi2, Morteza Koruji3,4.
Abstract
BACKGROUND: Prenatal drug exposure, as a common public health concern, is associated with an increased risk of adverse effects on early embryo development.Entities:
Keywords: Addiction; Apoptosis; Embryo development; Mouse; Preimplantation
Year: 2017 PMID: 29177242 PMCID: PMC5601932
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
Figure 1Schematic experimental design
Development of mouse morulae from addicted and non-addicted mothers in T6 media following 96-h cultivation
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|
| No. | 88 | 56 | 53 | 51 | 67 | |||
| 24 hr | ||||||||
| M | 3 (3.41) | 20 (35.71) | 25 (47.17) | 7 (13.73) | 31 (46.27) | |||
| Eb+Lb | 67 (76.14) | 35 (62.50) | 18 (33.96) | 37 (72.55) | 34 (50.75) | |||
| Hgb+Hdb | 17 (19.32) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |||
| D | 1 (1.13) | 1 (1.79) | 10 (18.87) | 7 13.73) | 2 (2.99) | |||
| 48 hr | ||||||||
| M | 0 (0.00) | 0 (0.00) | 1 (1.89) | 0 (0.00) | 0 (0.00) | |||
| Eb+Lb | 28 (31.82) | 22 (39.29) | 22 (41.51) | 30 (58.82) | 30 (44.78) | |||
| Hgb+Hdb | 53 (60.23) | 30 (53.57) | 19 (35.85) | 14 (27.45) | 24 (35.82) | |||
| D | 7 (7.95) | 4 (7.14) | 11 (20.75) | 7 13.73) | 13 (19.40) | |||
| 72 hr | ||||||||
| M | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |||
| Eb+Lb | 16 (18.18) | 7 (12.50) | 5 (9.43) | 13 (25.49) | 8 (11.94) | |||
| Hgb+Hdb | 58 (65.91) | 39 (69.64) | 37 (69.81) | 28 (54.90) | 41 (61.19) | |||
| D | 14 (15.91) | 10 (17.86) | 11 (20.75) | 10 (19.61) | 18 (26.87) | |||
| 96 hr | ||||||||
| M | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | |||
| Eb+Lb | 12 (13.64) | 7 (12.50) | 1 (1.89) | 3 (5.88) | 4 (5.97) | |||
| Hgb+Hdb | 62 (70.45) | 39 (69.64) | 38 (71.70) | 32 (62.75) | 42 (62.69) | |||
| D | 14 (15.91) | 10 (17.86) | 14 (26.42) | 16 31.37) | 21 (31.34) | |||
Data presented as n (%).
Control, embryos from non-addicted mothers in T6 medium
Vehicle, received only normal saline and lemon juice;
Exp. I, experimental group I received Kerack at a dose of 5 mg/kg after addiction to Kerack;
Exp. II, experimental group II received Kerack at a dose of 35 mg/kg after addiction to Kerack and
Exp. III, Experimental group III received Kerack at a dose of 70 mg/kg after addiction to Kerack.
M: morula
Eb: early blastocyst
Lb: late blastocyst
Hgb: hatching blastocyst
Hgd: hatched blastocyst
D: degenerated embryo.
Figure 2Differential staining in order to determine the number of blastomer cells and inner cell mass cells (ICM), differential staining was performed. The outer trophectoderm (TE) cells were identified by the pink fluorescence of propidium iodide, whereas the ICM cells were recognized by the blue fluorescence of bisbenzimide (Scale Bar=200µm).
The effect of Kerack on blastomer, ICM and apoptotic cell number in the blastocyst stage
|
|
|
|
|
|---|---|---|---|
| Control | 65.08±8.42 | 26.15±5.34 | 1.46±1.45 |
| Vehicle | 56.29±6.16 | 23.29±3.15 | 0.29±0.49 |
| Experimental I (5 mg/kg) | 46.17±4.15[ | 18.17±3.07 [ | 2.92±2.71 [ |
| Experimental II (35 mg/kg) | 46.44±6.46 [ | 18.11±2.32[ | 5.11±4.86[ |
| Experimental III (70 mg/kg) | 40.92±7.09[ | 17.17±3.21 [ | 7.17±2.89 [ |
Control, embryos from non-addicted mothers in T6 medium
Vehicle, received only normal saline and lemon juice;
Exp. I, experimental group I received Kerack at a dose of 5 mg/kg after addiction to Kerack;
Exp. II, experimental group II received Kerack at a dose of 35 mg/kg after addiction to Kerack and
Exp. III, Experimental group III received Kerack at a dose of 70 mg/kg after addiction to Kerack.
ICM: Inner Cell Mass
Significant difference versus control and vehicle groups (p<0.001).
Significant difference versus vehicle groups (p<0.05).
Significant difference versus vehicle groups (p<0.01).
Significant difference versus exp. 1 (5mg/kg) (p<0.01).
Figure 3TUNEL assay to detect apoptotic cells. The green cells indicate the TUNEL-positive apoptotic cells. (A-C) Negative control embryos (A TUNEL assay; B, DAPI staining; C, merged, ×200). (D-F) Positive control embryos (D, TUNEL assay; E, DAPI staining; F, merged×100). (G-I) Experimental group I(5mg/kg) (G, TUNEL assay; H, DAPI staining; I, merged×200). (J-L) Experimental group II (35mg/kg) (J, TUNEL assay; K, DAPI staining; L, merged×100). (M-O) Experimental group III (5mg/kg) (M, TUNEL assay; N, DAPI staining; O, merged×100). Kerack dose-dependently increased meaningfully the apoptotic cells in mouse blastocysts of the experimental group versus the control.